MedDataX Logo

Advancing Lung Cancer Screening One Text at a Time

NCT ID: NCT07227480

Last Updated: 2025-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Screening

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Lung Cancer Screening

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

UR Screened

A text messaging program designed to promote lung cancer screening

Group Type EXPERIMENTAL

Text messaging program

Intervention Type BEHAVIORAL

A text messaging program designed to promote lung cancer screening

Control group

A mailed educational material along with a flyer for the lung cancer screening program

Group Type ACTIVE_COMPARATOR

Educational material

Intervention Type BEHAVIORAL

A mailed educational material along with a flyer for the lung cancer screening program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Text messaging program

A text messaging program designed to promote lung cancer screening

Intervention Type BEHAVIORAL

Educational material

A mailed educational material along with a flyer for the lung cancer screening program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 50 to 80 years old
* have not completed their annual screening for lung cancer
* have a 20 pack-year smoking history
* currently smoke or have quit within the past 15 years
* speak English and/or Spanish
* have a functioning cellphone number with unlimited text messaging capacity
* be willing to complete a baseline and a follow-up (at Month 3) survey

Exclusion Criteria

* being up-to-date on their annual lung cancer screening
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rochester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francisco Cartujano, MD

Assistant Professor - Department of Public Health Sciences (SMD)

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francisco Cartujano, MD

Role: CONTACT

Phone: (585) 273-1646

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francisco Cartujano, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00010975

Identifier Type: -

Identifier Source: org_study_id